antibody psd95 ms 108e10 Search Results


95
Synaptic Systems antibody psd95 ms 108e10 synaptic systems
Antibody Psd95 Ms 108e10 Synaptic Systems, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibody+psd95+ms+108e10/124+011/10__7554_slash_elife__36217-272-26-30
Average 95 stars, based on 1 article reviews
antibody psd95 ms 108e10 synaptic systems - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Synaptic Systems psd 95
Psd 95, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibody+psd95+ms+108e10/124+002/pmc07117895-913-13-16
Average 94 stars, based on 1 article reviews
psd 95 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Merck & Co anti-actin
Anti Actin, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibody+psd95+ms+108e10/mab1501/10__1523_slash_jneurosci__2181___19__2020-101-21-23
Average 90 stars, based on 1 article reviews
anti-actin - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
Synaptic Systems rabbit polyclonal anti synapsin 1
Rabbit Polyclonal Anti Synapsin 1, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibody+psd95+ms+108e10/106+103/pmc05549836-154-6-12
Average 94 stars, based on 1 article reviews
rabbit polyclonal anti synapsin 1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
R&D Systems af2046 mouse 3f4
CRMP2 protein level and phosphorylation by GSK3β is unchanged in Crmp2 S517A mice. ( a ) Mouse brain lysates were probed with site-specific O-GlcNAc-CRMP2 antibody (OG-CRMP2) on western blot. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) signal was used as loading control. Replicates of five wild-type and Crmp2 S517A mice are shown. ( b ) Quantification of CRMP2 signal normalized to GAPDH signal based on blot shown in ( c ). ( c ) Western blot using P509/514-CRMP2 specific antibody and total CRMP2 antibody on mouse brain lysates. ( d ) Quantification of diphospho-CRMP2 signal normalized to total CRMP2 signal. ( e ) Western blot using quadrophospho-CRMP2 (P509/514/518/522) specific antibody, <t>3F4.</t> ( f ) Quantification of 3F4 signal, normalized to total CRMP2 signal.
Af2046 Mouse 3f4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibody+psd95+ms+108e10/Human%2FMouse+GATA-2+Antibody/pmc06893399-198-87-85
Average 93 stars, based on 1 article reviews
af2046 mouse 3f4 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc 9393 rabbit anti pan tuc crmp
CRMP2 undergoes dynamic O-GlcNAc post-translational modification at Ser517 in vivo . ( a ) Sequence alignment shows that the O-GlcNAcylation modification site on the C-terminal tail is unique to CRMP2 among other members of the <t>CRMP</t> family. The Ser517 O-GlcNAcylation site is in close proximity to several phosphorylation sites targeted by Cdk5 (dark green) and GSK3β (light green) kinases. ( b ) Western blotting for O-GlcNAc-CRMP2 (OG-CRMP2) on post-mortem human hippocampus samples ( n = 14, age range 17–89 years). ( c ) Correlation analysis reveals that the Pearson correlation coefficient for the OG-CRMP2 level versus age is 0.57, indicating a positive correlation. ( d ) O-GlcNAcylation of CRMP2 is post-translational. Neuro2A cells expressing Flag-tagged CRMP2 were treated with cycloheximide (CHX), a protein translation inhibitor, and subsequently supplemented with GlcNAcstatin G (GG) OGA inhibitor. Blocking translation did decrease CRMP2 protein levels, but it did not inhibit induction of O-GlcNAcylation on CRMP2. ( e ) O-GlcNAcylation of CRMP2 is inducible in vivo. Mice were infused (osmotic pump implant) with 10 mg ml −1 GG ( n = 3) or dose vehicle alone ( n = 3) at 8 µl h −1 for 24 h. Brain lysates were probed with site-specific OG-CRMP2 antibody on western blot. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
9393 Rabbit Anti Pan Tuc Crmp, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibody+psd95+ms+108e10/CRMP-2+Antibody/pmc06893399-198-28-26
Average 95 stars, based on 1 article reviews
9393 rabbit anti pan tuc crmp - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

Image Search Results


CRMP2 protein level and phosphorylation by GSK3β is unchanged in Crmp2 S517A mice. ( a ) Mouse brain lysates were probed with site-specific O-GlcNAc-CRMP2 antibody (OG-CRMP2) on western blot. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) signal was used as loading control. Replicates of five wild-type and Crmp2 S517A mice are shown. ( b ) Quantification of CRMP2 signal normalized to GAPDH signal based on blot shown in ( c ). ( c ) Western blot using P509/514-CRMP2 specific antibody and total CRMP2 antibody on mouse brain lysates. ( d ) Quantification of diphospho-CRMP2 signal normalized to total CRMP2 signal. ( e ) Western blot using quadrophospho-CRMP2 (P509/514/518/522) specific antibody, 3F4. ( f ) Quantification of 3F4 signal, normalized to total CRMP2 signal.

Journal: Open Biology

Article Title: Loss of CRMP2 O-GlcNAcylation leads to reduced novel object recognition performance in mice

doi: 10.1098/rsob.190192

Figure Lengend Snippet: CRMP2 protein level and phosphorylation by GSK3β is unchanged in Crmp2 S517A mice. ( a ) Mouse brain lysates were probed with site-specific O-GlcNAc-CRMP2 antibody (OG-CRMP2) on western blot. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) signal was used as loading control. Replicates of five wild-type and Crmp2 S517A mice are shown. ( b ) Quantification of CRMP2 signal normalized to GAPDH signal based on blot shown in ( c ). ( c ) Western blot using P509/514-CRMP2 specific antibody and total CRMP2 antibody on mouse brain lysates. ( d ) Quantification of diphospho-CRMP2 signal normalized to total CRMP2 signal. ( e ) Western blot using quadrophospho-CRMP2 (P509/514/518/522) specific antibody, 3F4. ( f ) Quantification of 3F4 signal, normalized to total CRMP2 signal.

Article Snippet: Rabbit anti-gSer517 OG-CRMP2 (1 : 1000) raised for this study by the van Aalten laboratory Rabbit anti-CRMP2 (1 : 2000) Millipore Rabbit anti-CRMP2 (1 : 2500) Cell Signalling 9393 Rabbit anti-pan-TUC (CRMP) (1 : 10 000) Millipore ABN108 Sheep anti-P-T509/514 CRMP2 (1 : 2000) with dephospho-peptide [ ] Mouse anti-O-GlcNAc /RL2 (1 : 2000) Abcam ab2739 Mouse anti-FLAG (M2) (1 : 5000) Sigma Mouse anti-PSD95 (SAP90, DLG4) (108E10) SYSY Rabbit anti-GAPDH (FL-335) (1 : 1000) Santa Cruz sc-25778 Goat anti-GATA-2 (0.5 µg ml −1 ) R&D Systems AF2046 Mouse 3F4 (1 µg ml −1 ) Takara 29060 Mouse NeuN (A60) (1 : 2000) Millipore MAB377 Licor 680, Licor 800

Techniques: Western Blot

CRMP2 undergoes dynamic O-GlcNAc post-translational modification at Ser517 in vivo . ( a ) Sequence alignment shows that the O-GlcNAcylation modification site on the C-terminal tail is unique to CRMP2 among other members of the CRMP family. The Ser517 O-GlcNAcylation site is in close proximity to several phosphorylation sites targeted by Cdk5 (dark green) and GSK3β (light green) kinases. ( b ) Western blotting for O-GlcNAc-CRMP2 (OG-CRMP2) on post-mortem human hippocampus samples ( n = 14, age range 17–89 years). ( c ) Correlation analysis reveals that the Pearson correlation coefficient for the OG-CRMP2 level versus age is 0.57, indicating a positive correlation. ( d ) O-GlcNAcylation of CRMP2 is post-translational. Neuro2A cells expressing Flag-tagged CRMP2 were treated with cycloheximide (CHX), a protein translation inhibitor, and subsequently supplemented with GlcNAcstatin G (GG) OGA inhibitor. Blocking translation did decrease CRMP2 protein levels, but it did not inhibit induction of O-GlcNAcylation on CRMP2. ( e ) O-GlcNAcylation of CRMP2 is inducible in vivo. Mice were infused (osmotic pump implant) with 10 mg ml −1 GG ( n = 3) or dose vehicle alone ( n = 3) at 8 µl h −1 for 24 h. Brain lysates were probed with site-specific OG-CRMP2 antibody on western blot. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.

Journal: Open Biology

Article Title: Loss of CRMP2 O-GlcNAcylation leads to reduced novel object recognition performance in mice

doi: 10.1098/rsob.190192

Figure Lengend Snippet: CRMP2 undergoes dynamic O-GlcNAc post-translational modification at Ser517 in vivo . ( a ) Sequence alignment shows that the O-GlcNAcylation modification site on the C-terminal tail is unique to CRMP2 among other members of the CRMP family. The Ser517 O-GlcNAcylation site is in close proximity to several phosphorylation sites targeted by Cdk5 (dark green) and GSK3β (light green) kinases. ( b ) Western blotting for O-GlcNAc-CRMP2 (OG-CRMP2) on post-mortem human hippocampus samples ( n = 14, age range 17–89 years). ( c ) Correlation analysis reveals that the Pearson correlation coefficient for the OG-CRMP2 level versus age is 0.57, indicating a positive correlation. ( d ) O-GlcNAcylation of CRMP2 is post-translational. Neuro2A cells expressing Flag-tagged CRMP2 were treated with cycloheximide (CHX), a protein translation inhibitor, and subsequently supplemented with GlcNAcstatin G (GG) OGA inhibitor. Blocking translation did decrease CRMP2 protein levels, but it did not inhibit induction of O-GlcNAcylation on CRMP2. ( e ) O-GlcNAcylation of CRMP2 is inducible in vivo. Mice were infused (osmotic pump implant) with 10 mg ml −1 GG ( n = 3) or dose vehicle alone ( n = 3) at 8 µl h −1 for 24 h. Brain lysates were probed with site-specific OG-CRMP2 antibody on western blot. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.

Article Snippet: Rabbit anti-gSer517 OG-CRMP2 (1 : 1000) raised for this study by the van Aalten laboratory Rabbit anti-CRMP2 (1 : 2000) Millipore Rabbit anti-CRMP2 (1 : 2500) Cell Signalling 9393 Rabbit anti-pan-TUC (CRMP) (1 : 10 000) Millipore ABN108 Sheep anti-P-T509/514 CRMP2 (1 : 2000) with dephospho-peptide [ ] Mouse anti-O-GlcNAc /RL2 (1 : 2000) Abcam ab2739 Mouse anti-FLAG (M2) (1 : 5000) Sigma Mouse anti-PSD95 (SAP90, DLG4) (108E10) SYSY Rabbit anti-GAPDH (FL-335) (1 : 1000) Santa Cruz sc-25778 Goat anti-GATA-2 (0.5 μg ml −1 ) R&D Systems AF2046 Mouse 3F4 (1 μg ml −1 ) Takara 29060 Mouse NeuN (A60) (1 : 2000) Millipore MAB377 Licor 680, Licor 800

Techniques: Modification, In Vivo, Sequencing, Phospho-proteomics, Western Blot, Expressing, Blocking Assay

Characterization of Crmp2 S517A mice reveals bodyweight phenotype ( a , b ). ( a ) Comparison of the body weights of WT and Crmp2 S517A mice at 12–25 weeks old. Data are expressed as the mean ± s.e.m. (WT, n = 8; Crmp2 S517A , n = 10) (male, n = 9; female, n = 9). Repeated measures ANOVA for the whole dataset, test of between-subject effect, genotype, F = 11.026, p = 0.005. ( b ) Comparison of the body weights of WT and Crmp2 S517A mice at 20 weeks old. Data are expressed as the mean ± s.d.; paired, two-tailed t -test (female, p = 0.0199; WT, n = 6; Crmp2 S517A , n = 7; male, p = 0.0125; WT, n = 6; Crmp2 S517A , n = 6). Histological analysis of brain samples from WT and Crmp2 S517A mice ( c – g ). Mean ± s.d.; WT, n = 5; Crmp2 S517A , n = 6. ( c ) Representative photomicrographs (left panels) show coronal sections stained with cresyl-violet (Nissl staining) in WT and Crmp2 S517A mice. NeuN immunolabelling (right panels) reveals Crmp2 S517A has no effect on neuronal viability in the dentate gyrus. ( d ) Ventricular volume (mm 3 ) for left and right lateral ventricles and third ventricle. WT (3.592 ± 1.155) and Crmp2 S517A (4.160 ± 1.252); n.s. ( e ) Cortical thickness (μm), measurement was taken at four points along the cortex in each animal. WT (1197 ± 175.4) and Crmp2 S517A (1127 ± 93.24); n.s. ( f ) Western blot shows comparable levels of O-GlcNAc CRMP2 (OG-CRMP2) in several brain regions in WT and Crmp2 S517A mice relative to total CRMP levels. ( g ) Western blot indicates presence of CRMP2 O-GlcNAcylation in cytoplasmic and synaptic cellular fractions.

Journal: Open Biology

Article Title: Loss of CRMP2 O-GlcNAcylation leads to reduced novel object recognition performance in mice

doi: 10.1098/rsob.190192

Figure Lengend Snippet: Characterization of Crmp2 S517A mice reveals bodyweight phenotype ( a , b ). ( a ) Comparison of the body weights of WT and Crmp2 S517A mice at 12–25 weeks old. Data are expressed as the mean ± s.e.m. (WT, n = 8; Crmp2 S517A , n = 10) (male, n = 9; female, n = 9). Repeated measures ANOVA for the whole dataset, test of between-subject effect, genotype, F = 11.026, p = 0.005. ( b ) Comparison of the body weights of WT and Crmp2 S517A mice at 20 weeks old. Data are expressed as the mean ± s.d.; paired, two-tailed t -test (female, p = 0.0199; WT, n = 6; Crmp2 S517A , n = 7; male, p = 0.0125; WT, n = 6; Crmp2 S517A , n = 6). Histological analysis of brain samples from WT and Crmp2 S517A mice ( c – g ). Mean ± s.d.; WT, n = 5; Crmp2 S517A , n = 6. ( c ) Representative photomicrographs (left panels) show coronal sections stained with cresyl-violet (Nissl staining) in WT and Crmp2 S517A mice. NeuN immunolabelling (right panels) reveals Crmp2 S517A has no effect on neuronal viability in the dentate gyrus. ( d ) Ventricular volume (mm 3 ) for left and right lateral ventricles and third ventricle. WT (3.592 ± 1.155) and Crmp2 S517A (4.160 ± 1.252); n.s. ( e ) Cortical thickness (μm), measurement was taken at four points along the cortex in each animal. WT (1197 ± 175.4) and Crmp2 S517A (1127 ± 93.24); n.s. ( f ) Western blot shows comparable levels of O-GlcNAc CRMP2 (OG-CRMP2) in several brain regions in WT and Crmp2 S517A mice relative to total CRMP levels. ( g ) Western blot indicates presence of CRMP2 O-GlcNAcylation in cytoplasmic and synaptic cellular fractions.

Article Snippet: Rabbit anti-gSer517 OG-CRMP2 (1 : 1000) raised for this study by the van Aalten laboratory Rabbit anti-CRMP2 (1 : 2000) Millipore Rabbit anti-CRMP2 (1 : 2500) Cell Signalling 9393 Rabbit anti-pan-TUC (CRMP) (1 : 10 000) Millipore ABN108 Sheep anti-P-T509/514 CRMP2 (1 : 2000) with dephospho-peptide [ ] Mouse anti-O-GlcNAc /RL2 (1 : 2000) Abcam ab2739 Mouse anti-FLAG (M2) (1 : 5000) Sigma Mouse anti-PSD95 (SAP90, DLG4) (108E10) SYSY Rabbit anti-GAPDH (FL-335) (1 : 1000) Santa Cruz sc-25778 Goat anti-GATA-2 (0.5 μg ml −1 ) R&D Systems AF2046 Mouse 3F4 (1 μg ml −1 ) Takara 29060 Mouse NeuN (A60) (1 : 2000) Millipore MAB377 Licor 680, Licor 800

Techniques: Comparison, Two Tailed Test, Staining, Western Blot